Filtered By:
Drug: Plavix
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 103 results found since Jan 2013.
Loading dose of Aspirin
Standard loading dose of Aspirin in acute coronary syndrome:
a) 150 mg
b) 300 mg
c) 450 mg
d) 600 mg
Correct answer: b) 300 mg
Standard loading dose of Aspirin and clopidogrel in acute coronary syndrome is 300 mg. Ideally the first dose of Aspirin has to be chewed, to enhance buccal absorption, with faster onset of action.
Source: Cardiophile MD - July 25, 2013 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin, FRCP London Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
Cardiology MCQ Test 6
Cardiology MCQ Online 6
Time limit: 0
Quiz-summary
0 of 25 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
You are welcome to try this MCQ set and share it among your friends. Answer key with explanation appears after you complete the test and submit it and press on the view questions button. W...
Source: Cardiophile MD - July 16, 2013 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
Cardiology MCQ Online 5
Time limit: 0
Quiz-summary
0 of 25 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
You are welcome to try this MCQ set and share it among your friends. Answer key with explanation appears after you complete the test and submit it and press on the view questions button. We strongly advise you t...
Source: Cardiophile MD - July 15, 2013 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
Cardiology MCQ Test 5
Cardiology MCQ Online 5
Time limit: 0
Quiz-summary
0 of 25 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
You are welcome to try this MCQ set and share it among your friends. Answer key with explanation appears after you complete the test and submit it and press on the view questions button. W...
Source: Cardiophile MD - July 15, 2013 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
Aspirin unneeded with anticoagulation/clopidogrel after MI, PCI in AF; vegetarian diet linked to longer life; FDA: Rosiglitazone does not up CV risk; New obesity drug, lorcaserin
Source: Blogs@theHeart.org - June 14, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
When anterior epicardial fat . . . generates Q waves . . . diagnosis of ASMI gets busted !
Q wave are neither sacred nor sinister waves . It represents either of the following .
Electrical activity that goes away from the recording electrode.
Or whenever there is a electrical insulation or hurdle that interrupts the flow of current towards the electrode ( and if it is sustained ) it can result in q waves (Minor interruption produces a notch or slurs . Please note a major slur becomes a q wave equivalent )
Here is young women of 42 years with a diagnosis of old anterior MI for over 5 years ( Getting a dedicated care from a cardiologist! The prescription included Imdur/Bet...
Source: Dr.S.Venkatesan MD - April 24, 2013 Category: Cardiology Authors: drsvenkatesan Tags: Cardiology - Electrophysiology -Pacemaker cardiology -ECG Cardiology -unresolved questions Clinical cardiology epicardial fat and q waves non infarct q waves pesdo infarct patterns in ecg Source Type: blogs
Cangrelor During PCI May Reduce Ischemic Events
In the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) trial, the intravenous platelet inhibitor cangrelor was tested for its effect on ischemic events associated with PCI. Cangrelor is a potent, fast-acting and reversible agent. Results of the trial were presented at the ACC in San Francisco and published simultaneously in the New England Journal of Medicine. A total of 11,145 PCI patients were randomized to a bolus and infusion of cangrelor or to a loading dose of clopidogrel. A primary endpoint event — death, MI, ischemia-driven revascularization, or stent...
Source: CardioBrief - March 10, 2013 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery antiplatelet Cangrelor clopidogrel PCI Source Type: blogs
Why Prasugrel is contraindicated in TIA ?
Take Our Poll
Current prescribing information cautions clearly Prasugrel should not be used in TIA or recent stroke (Even in ischemic strokes -Embolic included !)
The warning is perplexing and illogical to me.
What is your take ?
I would imagine the following could be the reasons.
Prasugrel as an antiplatlet agent is many fold powerful and could convert all strokes into hemorrhagic one .
Does Prasugrel convert a TIA into stroke instead of curing it ?
Prasugrel may worsen the stroke in case the TIA is going to end up as stroke.
Is there any thing called hemorrhagic TIA ?
Since we do not have ...
Source: Dr.S.Venkatesan MD - February 27, 2013 Category: Cardiology Authors: drsvenkatesan Tags: stroke Uncategorized Antipaltelet agents drugs controversy antipaltelt agents mainstay in tia prasugrel for tia prasugrel vs clopidogrel in TIA strke in evolution Source Type: blogs
#178: Short course of aspirin, clopidogrel cuts stroke risk; Lp(a) gene variant associated with aortic stenosis; MAGELLAN published: Rivaroxaban reduces VTE risk in acutely ill patients; weight-loss drug Qsymia improves cardiovascular risk profile
course of aspirin, clopidogrel cuts stroke risk; Lp(a) gene variant associated with aortic stenosis; MAGELLAN published: Rivaroxaban reduces VTE risk in acutely ill patients; weight-loss drug Qsymia improves cardiovascular risk profile
Source: Blogs@theHeart.org - February 15, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
Early Results: Antiplatelet Drug Cangrelor Appears Effective For PCI
The experimental antiplatelet drug cangrelor was superior to traditional clopidogrel in reducing ischemic events at 48 hours in PCI patients, according to the Medicines Company, which is developing the drug. The company today announced positive results from the phase 3 CHAMPION PHOENIX trial, a randomized, double-blind study comparing intravenous cangrelor to oral clopidogrel in PCI patients. The primary endpoint was the composite of death, MI, revascularization and stent thrombosis at 48 hours. Click here to read the full story on Forbes.
Source: CardioBrief - January 8, 2013 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery Antiplatelet drug Cangrelor clopidogrel Conventional PCI Medicines Company Stent Source Type: blogs
Precordial ST depression. What is the diagnosis?
A middle aged male with no h/o CAD presented with one week of crescendo exertional angina, and had chest pain at the time of the first ECG:Here is the patient's previous ECG:NormalHere is the patient's presenting ED ECG:What do you think?There is isolated ST depression in precordial leads, deeper in V2 - V4 than in V5 or V6. There is no ST elevation. Precordial ST depression may be subendocardial ischemia or posterior STEMI. How can we tell the difference? See the list below.If you thought it might be a posterior STEMI, then you might have ordered a posterior ECG [change leads V4...
Source: Dr. Smith's ECG Blog - January 1, 2013 Category: Cardiology Authors: Steve Smith Source Type: blogs
